Identification of peptide sequences that potentially trigger HLA‐A2.1‐restricted cytotoxic T lymphocytes
Hans W. Nijman(University Medical Center Groningen), W. Martin Kast(University of Southern California), Sjoerd H. van der Burg(Leiden University Medical Center), Peter Kenemans, Michel Vierboom(Biomedical Primate Research Centre), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), J. D‘Amaro, J. G. A. Houbiers(Leiden University), Jan W. Drijfhout(Leiden University)
Cited by 194
Related Papers
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
|British Journal of Cancer|2011|1.3k
Therapeutic cancer vaccines
|Journal of Clinical Investigation|2015|1.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
Tumor-infiltrating lymphocytes in the immunotherapy era
|Cellular and Molecular Immunology|2020|919